A case report of long-term successful use of maintenance therapy with PARP inhibitors in the primary treatment of advanced BRCA-associated ovarian cancer by О. N. Churuksaeva, L. А. Kolomiets, А. B. Villert

Subjects: Get full text

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors by Álvaro Lahiguera, Petra Hyroššová, Agnès Figueras, Diana Garzón, Roger Moreno, Vanessa Soto‐Cerrato, Iain McNeish, Violeta Serra, Conxi Lazaro, Pilar Barretina, Joan Brunet, Javier Menéndez, Xavier Matias‐Guiu, August Vidal, Alberto Villanueva, Barbie Taylor‐Harding, Hisashi Tanaka, Sandra Orsulic, Alexandra Junza, Oscar Yanes, Cristina Muñoz‐Pinedo, Luís Palomero, Miquel Àngel Pujana, José Carlos Perales, Francesc Viñals

Subjects: Get full text

A PARP inhibitors in the treatment of breast cancer - A Review of literature by Jagoda Niewiadomska, Borys Bondos, Aleksandra Stępień, Alicja Paluch, Jakub Skrzypek, Aleksandra Niekra, Łukasz Fussek, Robert Kochan, Ewelina Wieczorek, Kacper Lee

Subjects: “…PARP inhibitors…”
Get full text

Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients by Maria Delgado-Ortet, Maria Delgado-Ortet, Vlad Bura, Vlad Bura, Vlad Bura, Vlad Bura, Ionut-Gabriel Funingana, Ionut-Gabriel Funingana, Ionut-Gabriel Funingana, Ionut-Gabriel Funingana, David Hulse, David Hulse, David Hulse, Leonardo Rundo, Leonardo Rundo, Leonardo Rundo, James D. Brenton, James D. Brenton, James D. Brenton, James D. Brenton, Evis Sala, Evis Sala, Evis Sala, Evis Sala, Evis Sala, Lorena Escudero Sanchez, Lorena Escudero Sanchez

Subjects: Get full text

Bibliometric analysis of research trends on the combination of radiotherapy and PARP inhibitors in solid tumors by Yuxin Chen, Zhengkun Zhang, Zhengkun Zhang, Rutie Yin, Rutie Yin, Qingli Li, Qingli Li, Wenhao Zhang, Wenhao Zhang

Subjects: “…PARP inhibitors…”
Get full text

PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies by Shant Apelian, Antons Martincuks, Michelle Whittum, Maya Yasukawa, Lindsey Nguy, Begum Mathyk, Vaagn Andikyan, Matthew L. Anderson, Thomas Rutherford, Mihaela Cristea, Daphne Stewart, Adrian Kohut

Subjects: “…PARP inhibitors…”
Get full text

HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer by Shuran Tan, Fang Zhu, Yi Li, Xinxin Wen, Siyu Yang, Zexi Liao, Xuerui Duan, Di Xiao, Yu Zhang

Subjects: Get full text

Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors by Hasset Tibebe, Dacia Marquez, Aidan McGraw, Sophia Gagliardi, Cailyn Sullivan, Grace Hillmer, Kedhar Narayan, Coco Izumi, Adleigh Keating, Taisuke Izumi

Subjects: Get full text

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA by Alessandra Virga, Milena Urbini, Maurizio Polano, Elisabetta Petracci, Gianluca Tedaldi, Giorgia Gurioli, Giorgia Marisi, Davide Angeli, Andrea Ambrosini-Spaltro, Giovanni De Luca, Ilaria Cangini, Valentina Zampiga, Giovanna Cenacchi, Giuseppe Toffoli, Chiara Casadei, Maria Concetta Cursano, Vincenza Conteduca, Ugo De Giorgi, Paola Ulivi

Subjects: Get full text

PARP inhibitors in melanoma treatment: potential, challenges, and future directions by Angela Anaeme, Karen Moussa, Abdallah N. Mansour, George Nassief, George Ansstas

Subjects: “…PARP inhibitors…”
Get full text

HEREDITARY BREAST CANCER by E. M. Bit-Sava, N. B. Belogurova

Subjects: Get full text

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation by Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir Hussein Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles‐Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, Maria Vidal, Vicente Peg, Xavier Serres‐Créixams, Graham Dellaire, Jacques Simard, Paolo Nuciforo, Isabel T Rubio, Rodrigo Dienstmann, J Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J O'Connor, Orland Díez, Judith Balmaña, Violeta Serra

Subjects: Get full text

Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance by Desirèe Speranza, Fausto Omero, Vincenzo Cianci, Mariapia Marafioti, Carla Infurna, Patrizia Carroccio, Edoardo Spina, Maria Antonietta Barbieri, Emanuela Esposito, Nicola Silvestris, Mariacarmela Santarpia

Subjects: Get full text

High-Risk Factors and Therapeutic Advances in Ovarian Cancer by Xiaoyu SHA, Weiwei ZUO, Jing GAN, Yankun LIU

Subjects: Get full text

Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in <i>BRCA1/2</i>-Proficient Cancer Cells by Danyang Zhou, Wei Liu, Yanyan Zhang, Chong Li

Subjects: “…PARP inhibitors…”
Get full text

PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology by Barbara Morone, Giovanna Grimaldi

Subjects: Get full text

The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments – parallels with other neurodegenerative disorders by Dahlia A. Ordaz, Kalpna Gupta, Daniela A. Bota, Daniela A. Bota, Daniela A. Bota, Daniela A. Bota

Subjects: Get full text

Hereditary breast and ovarian cancer syndrome (BRCA) gene: Concept, pathways, therapeutics, and future by Anup Tamhankar, Tanuja Tamhankar

Subjects: Get full text

Targeted but Troubling: CYP450 Inhibition by Kinase and PARP Inhibitors and Its Clinical Implications by Martin Kondža, Josipa Bukić, Ivan Ćavar, Biljana Tubić

Subjects: Get full text

Challenges and opportunities to address the emerging burden of targeted therapies in ovarian cancer by Salamatu Abdul-Aziz, Nawaraj Bhattarai, Luke Vale, Gurdeep S Sagoo, Asima Mukhopadhyay

Subjects: Get full text